Rite Aid

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through following segments: Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Earnings data Q1 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Rite Aid is a drugstore chain that offers prescription medications, over-the-counter drugs, and health and wellness products. Rite Aid is reshaping the concept of a modern pharmacy by catering to customer demands through various convenient channels, including retail and delivery pharmacy services. Additionally, the company's offerings extend to services provided by its wholly-owned subsidiaries, namely Elixir, Bartell Drugs, and Health Dialog. Elixir, Rite Aid’s pharmacy benefits and services company, encompasses accredited mail and specialty pharmacies, prescription discount programs, and an advanced adjudication platform. These components combine to provide exceptional member experiences and substantial cost savings. Furthermore, Health Dialog delivers healthcare coaching and disease management services through interactive live online sessions and phone-based health services.

Rite Aid is a health products and services company with 2,400 locations across 17 states.

The company's omnichannel business includes digital, retail, and delivery touchpoints. Rite Aid is a top 20 seller of speciality medications, per its investor website.

In addition to its retail business, Rite Aid owns a pharmacy benefits subdivision (Elixir) and a personalized health services and coaching arm, Health Dialog, which has served 10MM members as of May 2022.

The company has reported $1.85 billion of liquidity with no debt maturities until 2025. According to its investor website, Rite Aid expects to be free cash flow (FCF) positive in FY23.

In Q2 2022, Rite Aid shared a three-part growth strategy aimed at deepening market share, expanding into new markets, and creating new offerings.

To grow the current business, Rite Aid is aiming to increase its e-commerce and digital sales, refresh its loyalty program, and grow its specialty pharmacy offering, which focuses on serving customers with complex health conditions.

New market expansion plans include increasing Rite Aid's footprint of "small format" pharmacies in underserved communities and implementing "store within a store" partnerships.

Rite Aid also aims to grow via new offerings, such as expanded health plan and health system clinical services, a pharmacy benefit manager (PBM) as a service offering, and new strategic partnerships.

Rite Aid Investor Relations

*This is not investment advice.

PHILADELPHIA--(BUSINESS WIRE)--Elixir, a wholly owned subsidiary of Rite Aid (NYSE: RAD), announced the launch of a specialty generic medication enhancement to its managed copay solutions effective June 1, 2022. The enhancement allows members to receive generic versions of certain specialty medications at a $0 copay and has the potential to provide an average savings of up to $40,000 annually. “As specialty drug costs continue to climb and account for a significant amount of drug spend, Elixir

Elixir Launches Specialty Generic Enhancement that Leads to Thousands in Annual Savings for Plan Sponsors and Members

Block

Fear of falling tech stocks and crypto is deterring people from buying SQ stock, but savvy investors shouldn't ignore this opportunity. The post Block Stock Traders Are Ignoring the Rite-Aid Collab, but Shouldn't appeared first on InvestorPlace.

Block Stock Traders Are Ignoring the Rite-Aid Collab, but Shouldn't

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid Corporation (NYSE: RAD) (“Rite Aid” or the “Company”) announced today the early tender results of its previously announced series of tender offers (the “Tender Offers”) to purchase for cash certain of its outstanding series of senior notes listed in the table below (collectively, the “Notes”) for an aggregate purchase price, excluding accrued and unpaid interest, of up to $150,000,000 (the “Maximum Aggregate Cap”). The Tender Offers are being made pursu

Rite Aid Announces Early Results of Cash Tender Offers for Outstanding Debt Securities

The pharmacy chain's earnings report was just what the doctor ordered.

Why Rite Aid Stock Soared on Thursday

Rite Aid Corporation (NYSE:RAD ) Q1 2023 Results Conference Call June 23, 2022 8:30 AM ET Company Participants Byron Purcell - Investor Relations Heyward Donigan - President & CEO Matt Schroeder - EVP & CFO Andre Persaud - EVP & CRO, Elixir Chris DuPaul - COO, Elixir Conference Call Participants George Hill - Deutsche Bank Elizabeth Anderson - Evercore William Reuter - Bank of America Karru Martinson - Jefferies Jenna Giannelli - Goldman Sachs Carla Casella - JPMorgan Operator Good morning. My name is Regina, and I will be your conference operator today.

Rite Aid Corporation (RAD) CEO Heyward Donigan on Q1 2023 Results - Earnings Call Transcript

Rite Aid (RAD) stock is running higher Thursday morning after the company revealed its earnings report for the fiscal first quarter of 2023. The post Rite Aid (RAD) Stock Pops on Q1 Revenue Beat appeared first on InvestorPlace.

Rite Aid (RAD) Stock Pops on Q1 Revenue Beat

Shares of Rite Aid Corporation (NYSE:RAD) were last seen 9.5% higher to trade at $7.35, following an upbeat first-quarter earnings report.

Options Traders Target Rite Aid Stock After Beat-and-Raise

Rite Aid Corp (NYSE: RAD) shares are trading higher Thursday after the company announced better-than-expected financial results and raised full-year revenue guidance above analyst estimates. Rite Aid reported fiscal first-quarter revenue of $6.01 billion, which beat the estimate of $5.75.

Why Rite Aid Stock Is Rising Today

Rite Aid Corp (NYSE: RAD) has reported Q1 FY23 sales of 6.01 billion, down 2.4% Y/Y, beating the consensus of $5.75 billion.  The company reported an EPS loss of $(0.60) compared to an income of $0.38 a year ago, driven by non-cash impairment charges and cycling prior-year COVID.

Rite Aid Shares Jump After Upbeat Annual Guidance

The pharmacy chain reported a smaller loss than Wall Street had penciled in. Sales were higher than expected.

Rite Aid Stock Gains as Revenue Forecast Rises

Rite Aid Corp. RAD, +6.17% shares rose 4.8% in Thursday premarket trading after the pharmacy retailer reported first-quarter revenue that beat expectations and raised its full-year guidance. Net loss totaled $110.2 million, or $2.03 per share, after a loss of $13.1 million, or 24 cents per share, last year.

Rite Aid reports a revenue beat, raises guidance

PHILADELPHIA--(BUSINESS WIRE)--Rite Aid Corporation (NYSE: RAD) today reported operating results for its first fiscal quarter ended May 28, 2022. “We continue to make strides on our journey to transform Rite Aid and define the modern pharmacy. In the first quarter we increased our non-COVID prescriptions, reduced SG&A, built momentum at Elixir and delivered solid results across the business. The entire Rite Aid team looks forward to advancing our pharmacists' role in improving health outcom

Rite Aid Corporation Reports Fiscal 2023 First Quarter Results

Darden Restaurants

KB Home

Winnebago

The three major U.S. equity indexes closed mixed Friday with the Dow Jones industrials closing down about 0.1%, while the S&P 500 closed up 0.2% and the Nasdaq closed up 1.4%.

Earnings Previews: Darden Restaurants, KB Home, Rite Aid, Winnebago

PHILADELPHIA--(BUSINESS WIRE)--Following FDA authorization and new CDC recommendations, select Rite Aid (NYSE: RAD) locations – including Bartell Drugs, owned by Rite Aid Corporation, will be providing Pfizer-BioNTech COVID-19 vaccines to children ages 3 and over once shipments arrive to select pharmacies later this week. Rite Aid pharmacists are trained to administer vaccines down to the age of 3. Parents or guardians can schedule eligible children using Rite Aid's scheduling tool, https://www

Scheduling for COVID-19 Vaccinations for Children Ages 3 and Over Now Available at Rite Aid and Bartell Drug locations

Strong underlying business and robust digital and retail growth are expected to aid Rite Aid (RAD) in Q1. Its Retail Pharmacy segment is likely to be a key contributor despite supply headwinds.

What is Likely to Drive Rite Aid's (RAD) Earnings in Q1?

FedEx

CarMax

Lennar

Earnings season is winding down, but these companies still have to report results in coming days amid a difficult market environment. The post 4 Stocks Reporting Earnings the Week of June 20 appeared first on InvestorPlace.

4 Stocks Reporting Earnings the Week of June 20

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid Corporation (NYSE: RAD) (“Rite Aid” or the “Company”) announced today the commencement of a series of tender offers to purchase for cash certain of its outstanding series of senior notes listed in the table below (collectively, the “Notes”) for an aggregate purchase price, excluding accrued and unpaid interest, of up to $150,000,000 (the “Maximum Aggregate Cap”). Dollars per $1,000 Principal Amount of Notes(3)   Title of Security CUSIP Number Principal

Rite Aid Announces Cash Tender Offers for Outstanding Debt Securities

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid Corporation (NYSE: RAD) said today that it will release financial results for its Fiscal 2023 First Quarter, which ended May 28, 2022, on Thursday, June 23, 2022. The company will hold an analyst call at 8:30 a.m. Eastern Time with remarks by Rite Aid's management team. The call will be broadcast via the Internet at https://investors.riteaid.com. The telephone replay will be available beginning at 12:00 p.m. Eastern Time on Thursday, June 23, 2022, and

Rite Aid to Release First Quarter Results on June 23

Rite Aid's leadership team is highlighting the drugstore chain's growing pharmacy benefit management company amid buyout rumblings for the U.S. drugstore chain.

Rite Aid Touts PBM, Other Assets Amid Buyout Rumblings

Partnership to Increase Access to Comprehensive Care for Americans Living in Rural Areas SAN FRANCISCO , May 31, 2022 /PRNewswire/ -- Today, Homeward, a company committed to improving access to high-quality, comprehensive care in rural communities, announced a strategic partnership with Rite Aid (NYSE: RAD) to provide access to comprehensive care for those living in rural areas across the U.S. Rite Aid and Homeward partner to provide access to comprehensive care for those living in rural areas across the U.S Pharmacists are among the most trusted members of a local community – especially for the more than 50 percent of Americans living with a chronic condition[1]. Today, Rite Aid has over 6,300 pharmacists across 2,300 locations, including 700 pharmacy locations in rural areas, many of which are healthcare deserts with limited access to doctors and hospitals.

RITE AID AND HOMEWARD PARTNER TO SUPPORT SENIORS IN UNDERSERVED COMMUNITIES

Rite Air Corp. RAD, -4.69% said Friday that the COVID-19 boosters for 5-to-11 year olds made by Pfizer Inc. PFE, +2.13% and BioNTech SE BNTX, -3.70% are available at its drug stores and at Bartell Drugs, which it owns. The booster for that age group was authorized by the Food and Drug Administration earlier this week, and the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices recommended Thursday in favor of kids that age group getting the booster five months after their second dose.

Rite Aid and its Bartell Drugs has COVID-19 boosters for 5-to-11 year olds available

PHILADELPHIA--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) today announced it will begin administering a booster dose of Pfizer's COVID-19 vaccine at select locations for eligible children ages 5 to 11, following approval by the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) on Thursday. Bartell Drugs, owned by Rite Aid Corporation, will also begin administering boosters to this age group at select Seattle and Western Washington locations. Children in this

COVID-19 Boosters Now Available at Rite Aid and Bartell Drugs Locations for Eligible Children Ages 5 – 11

SAN FRANCISCO--(BUSINESS WIRE)--Afterpay, the leader in "Buy Now, Pay Later" (BNPL) payments, and trusted care retailer Rite Aid (NYSE: RAD) announced their partnership today, offering Rite Aid's online shoppers a new way to pay for everyday items in four installments at no additional cost when you pay on time. This partnership will help customers access and spend responsibly on everyday goods with Afterpay's powerful budgeting tool. “Our relationship with Rite Aid, and expansion into drugstore

Rite Aid and Afterpay Partner to Offer ‘Buy Now, Pay Later' on Everyday Items

Apple

Costco

Ford Motor Company

Alphabet

Lowe's

Norwegian Cruise Line

Fortress-like is the term you want to hear.

Balance Sheet Breakdown: Separating the Strong From the Weak

PHILADELPHIA--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) today announced that nearly 98% of its retail pharmacies across the 17 states it serves now offers FDA-authorized COVID-19 oral antiviral medications, Pfizer's Paxlovid or Merck's Molnupiravir, with a prescription from their healthcare provider. “Rite Aid continues to be a vital resource for our communities as we help customers navigate the COVID pandemic, and we are proud to now have these medications widely available across our footprint,” s

News for Rite Aid Stock (RAD)